iifl-logo-icon 1

Poly Medicure Ltd Share Price

2,097.5
(-0.58%)
Jul 19, 2024|09:44:59 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open2,115.9
  • Day's High2,118.1
  • 52 Wk High2,236.6
  • Prev. Close2,109.65
  • Day's Low2,091.25
  • 52 Wk Low1,091.25
  • Turnover (lac)66.57
  • P/E80.45
  • Face Value5
  • Book Value154.82
  • EPS26.23
  • Mkt. Cap (Cr.)20,130
  • Div. Yield0.14
No Records Found

Poly Medicure Ltd KEY RATIOS

Sector

Healthcare

Open

2,115.9

Prev. Close

2,109.65

Turnover(Lac.)

66.57

Day's High

2,118.1

Day's Low

2,091.25

52 Week's High

2,236.6

52 Week's Low

1,091.25

Book Value

154.82

Face Value

5

Mkt Cap (₹ Cr.)

20,130

P/E

80.45

EPS

26.23

Divi. Yield

0.14

Poly Medicure Ltd Corporate Action

9 May 2023

12:00 AM

Dividend

Dividend Amount: 3

arrow

6 Sep 2023

12:00 AM

AGM

Announcement Date: 06 Sep, 2023

arrow

25 Jun 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

6 Sep 2023

12:00 AM

BookCloser

arrow

Poly Medicure Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Poly Medicure Ltd SHAREHOLDING SNAPSHOT

20 Jul, 2024|03:05 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.22%

Foreign: 0.21%

Indian: 52.92%

Non-Promoter- 19.59%

Institutions: 19.59%

Non-Institutions: 27.25%

Custodian: 0.00%

Share Price

Poly Medicure Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

47.97

47.95

47.94

44.12

Preference Capital

0

0

0

0

Reserves

1,186.15

1,029.02

906.07

385.16

Net Worth

1,234.12

1,076.97

954.01

429.28

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

747.38

646.16

508.43

439.49

yoy growth (%)

15.66

27.08

15.68

11.41

Raw materials

-246.75

-199.94

-161.57

-146.42

As % of sales

33.01

30.94

31.77

33.31

Employee costs

-130.74

-127.34

-93.92

-81.39

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

173.38

121.78

96.35

76.26

Depreciation

-46.31

-39.28

-28.4

-22.95

Tax paid

-43.87

-29.4

-26.15

-20.06

Working capital

59.66

10.03

29.99

32.47

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

15.66

27.08

15.68

11.41

Op profit growth

30.08

33.57

29.8

9.34

EBIT growth

30.01

31.73

27.9

13.89

Net profit growth

40.19

31.6

24.9

18.79

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

1,375.8

1,115.23

923.06

786.47

687.24

Excise Duty

0

0

0

0

0

Net Sales

1,375.8

1,115.23

923.06

786.47

687.24

Other Operating Income

0

0

0

0

0

Other Income

61.27

38.11

40.35

21.73

20.6

Poly Medicure Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

6,520.85

92.7393,706.62238.80.091,894.6536.28

Max Healthcare Institute Ltd

MAXHEALTH

934.55

132.0290,718.3241.770.16610.1179.02

Fortis Healthcare Ltd

FORTIS

488.2

297.8736,879.7168.330.2307.48120.36

Global Health Ltd

MEDANTA

1,204.1

89.6332,296.0792.240578.65106.09

Narayana Hrudayalaya Ltd

NH

1,242.4

59.8325,393.87158.090.32846.3190.04

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Poly Medicure Ltd

Management

Register Office

Registrar Office

Chairman & Independent Directo

Devendra Raj Mehta

Non-Exec & Non-Independent Dir

Jugal Kishore Baid

Non-Exec. & Independent Dir.

Prakash Chand Surana

Managing Director & CEO

Himanshu Baid

Joint Managing Director

Rishi Baid

Non-Exec. & Independent Dir.

Shailendra Raj Mehta

Non-Exec & Non-Independent Dir

Mukulika Baid

Company Sec. & Compli. Officer

Avinash Chandra

Non-Exec. & Independent Dir.

Sandeep Bhargava

Non-Exec & Non-Independent Dir

Alessandro Balboni

Non-Exec. & Independent Dir.

Amit Khosla

Non-Exec. & Independent Dir.

Sonal Matto

Independent Director

Ambrish Mithal

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Poly Medicure Limited was incorporated on 30th March 1995. The Company is a manufacturer/producer of Medical Devices. It manufactures and supply, in India and internationally, a diverse portfolio of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices and others. The Companys product portfolio comprises of more than 130 SKUs of medical devices in the product verticals of infusion therapy, oncology, anesthesia and respiratory care, urology, gastroenterology, blood management and blood collection, surgery and wound drainage, dialysis, central venous access catheters, veterinary medical devices, and others. It currently operate 10 manufacturing facilities across India, China, Egypt and Italy. In India, it operate 7 manufacturing facilities, four of which are situated at Faridabad (Haryana), and 2 in Jaipur (Rajasthan) and 1 in Haridwar (Uttarakhand). It operate 1 manufacturing facility in China through its wholly owned subsidiary Poly Medicure (Laiyang) Company Limited.The Company started commercial production by April 97 with an installed capacity of Medical Disposables (16500000 Nos ) and Cold/Hot Therapy Packs (500000 Nos).During the year 1997-98, the company produced 51.06 lac nos. of Medical Disposables which constitute 42.60% of the installed capacity utilisati
Read More

Company FAQs

What is the Poly Medicure Ltd share price today?

Down Arrow

The Poly Medicure Ltd shares price on N/A is Rs.₹2105.4 today.

What is the Market Cap of Poly Medicure Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Poly Medicure Ltd is ₹20205.82 Cr. as of 19 Jul ‘24

What is the PE and PB ratio of Poly Medicure Ltd?

Down Arrow

The PE and PB ratios of Poly Medicure Ltd is 80.45 and 13.89 as of 19 Jul ‘24

What is the 52 Week High and Low of Poly Medicure Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Poly Medicure Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Poly Medicure Ltd is ₹1092.35 and ₹2235.3 as of 19 Jul ‘24

What is the CAGR of Poly Medicure Ltd?

Down Arrow

Poly Medicure Ltd's CAGR for 5 Years at 63.88%, 3 Years at 29.47%, 1 Year at 90.79%, 6 Month at 45.57%, 3 Month at 34.11% and 1 Month at 7.41%.

What is the shareholding pattern of Poly Medicure Ltd?

Down Arrow

The shareholding pattern of Poly Medicure Ltd is as follows:
Promoters - 53.15 %
Institutions - 19.60 %
Public - 27.26 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.